Reaping the rewards of a simplified dosing regimen

被引：0
作者：
Penson, Peter E. [1 ,2 ]
Banach, Maciej [2 ,3 ,4 ,5 ]
机构：
[1] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Clin Pharm & Therapeut Res Grp, Liverpool, England
[2] Liverpool Ctr Cardiovasc Sci, Liverpool, England
[3] John Paul II Catholic Univ Lublin, Fac Med, Lublin, Poland
[4] Med Univ Lodz MUL, Dept Prevent Cardiol & Lipidol, Lodz, Poland
[5] Johns Hopkins Univ, Ciccarone Ctr Prevent Cardiovasc Dis, Sch Med, Baltimore, MD 21218 USA
来源：
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY | 2024年 / 10卷 / 08期
关键词：
D O I：
10.1093/ehjcvp/pvae073
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：694 / 696
页数：3
相关论文
共 16 条
[1]   Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP) [J].
Banach, Maciej ;
Penson, Peter E. ;
Farnier, Michel ;
Fras, Zlatko ;
Latkovskis, Gustavs ;
Laufs, Ulrich ;
Paneni, Francesco ;
Parini, Paolo ;
Pirro, Matteo ;
Reiner, Zeljko ;
Vrablik, Michal ;
Escobar, Carlos .
PROGRESS IN CARDIOVASCULAR DISEASES, 2023, 79 :2-11
[2]   Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP) [J].
Banach, Maciej ;
Penson, Peter E. ;
Vrablik, Michal ;
Bunc, Matjaz ;
Dyrbus, Krzysztof ;
Fedacko, Jan ;
Gaita, Dan ;
Gierlotka, Marek ;
Jarai, Zoltan ;
Magda, Stefania Lucia ;
Margetic, Eduard ;
Margoczy, Roman ;
Durak-Nalbantic, Azra ;
Ostadal, Petr ;
Pella, Daniel ;
Trbusic, Matias ;
Udroiu, Cristian Alexandru ;
Vlachopoulos, Charalambos ;
Vulic, Dusko ;
Fras, Zlatko ;
Dudek, Dariusz ;
Reiner, Zeljko .
PHARMACOLOGICAL RESEARCH, 2021, 166
[3]   What have we learned about lipids and cardiovascular risk from PCSK9 inhibitor outcome trials: ODYSSEY and FOURIER? [J].
Banach, Maciej ;
Penson, Peter E. .
CARDIOVASCULAR RESEARCH, 2019, 115 (03) :E26-E31
[4]   2023 ESC Guidelines for the management of acute coronary syndromes [J].
Byrne, Robert A. ;
Rossello, Xavier ;
Coughlan, J. J. ;
Barbato, Emanuele ;
Berry, Colin ;
Chieffo, Alaide ;
Claeys, Marc J. ;
Dan, Gheorghe-Andrei ;
Dweck, Marc R. ;
Galbraith, Mary ;
Gilard, Martine ;
Hinterbuchner, Lynne ;
Jankowska, Ewa A. ;
Juni, Peter ;
Kimura, Takeshi ;
Kunadian, Vijay ;
Leosdottir, Margret ;
Lorusso, Roberto ;
Pedretti, Roberto F. E. ;
Rigopoulos, Angelos G. ;
Gimenez, Maria Rubini ;
Thiele, Holger ;
Vranckx, Pascal ;
Wassmann, Sven ;
Wenger, Nanette Kass ;
Ibanez, Borja ;
ESC Sci Document Grp .
EUROPEAN HEART JOURNAL, 2023, 44 (38) :3720-3826
[5]   How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitors [J].
Cybulska, Barbara ;
Klosiewicz-Latoszek, Longina ;
Penson, Peter E. ;
Nabavi, Seyed Mohammad ;
Lavie, Carl J. ;
Banach, Maciej .
PROGRESS IN CARDIOVASCULAR DISEASES, 2021, 67 :65-74
[6]   Inclisiran-New hope in the management of lipid disorders? [J].
Dyrbus, Krzysztof ;
Gasior, Mariusz ;
Penson, Peter ;
Ray, Kausik K. ;
Banach, Maciej .
JOURNAL OF CLINICAL LIPIDOLOGY, 2020, 14 (01) :16-27
[7]   Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel [J].
Ference, Brian A. ;
Ginsberg, Henry N. ;
Graham, Ian ;
Ray, Kausik K. ;
Packard, Chris J. ;
Bruckert, Eric ;
Hegele, Robert A. ;
Krauss, Ronald M. ;
Raal, Frederick J. ;
Schunkert, Heribert ;
Watts, Gerald F. ;
Boren, Jan ;
Fazio, Sergio ;
Horton, Jay D. ;
Masana, Luis ;
Nicholls, Stephen J. ;
Nordestgaard, Borge G. ;
van de Sluis, Bart ;
Taskinen, Marja-Riitta ;
Tokgozoglu, Lale ;
Landmesser, Ulf ;
Laufs, Ulrich ;
Wiklund, Olov ;
Stock, Jane K. ;
Chapman, M. John ;
Catapano, Alberico L. .
EUROPEAN HEART JOURNAL, 2017, 38 (32) :2459-2472
[8]   Reincarnated medicines: using out-dated drugs for novel indications [J].
Ferrari, Roberto ;
Luscher, Thomas F. .
EUROPEAN HEART JOURNAL, 2016, 37 (33) :2571-2576
[9]   Embracing the polypill as a cardiovascular therapeutic: is this the best strategy? [J].
Franczyk, Beata ;
Gluba-Brzozka, Anna ;
Jurkiewicz, Lukasz ;
Penson, Peter ;
Banach, Maciej ;
Rysz, Jacek .
EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (17) :1857-1865
[10]   Eliminating atherosclerotic cardiovascular disease residual risk [J].
Makover, Michael E. ;
Surma, Stanislaw ;
Banach, Maciej ;
Toth, Peter P. .
EUROPEAN HEART JOURNAL, 2023, 44 (45) :4731-4733
12